Surgical Treatment Intensity at the End of Life in Patients With Cancer: A Systematic Review
Objective:. To synthesize evidence of surgical treatment intensity, defined as a measure of the quantity of invasive procedures, received by patients in patients with cancer within a defined time period around the ‘end of life’ (EoL). Background:. Concern regarding overly ‘aggressive’ care or high h...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Health
2024-12-01
|
| Series: | Annals of Surgery Open |
| Online Access: | http://journals.lww.com/10.1097/AS9.0000000000000514 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832589685316124672 |
|---|---|
| author | Samuel Lawday, BMBS, MByRes Benjamin E. Zucker, MA, MBBS, MRCS Shona Gardner, MBChB, MRCS James Robb, MBChB, MA Lorna Leandro, MA, BM, BCh William Hollingworth, PhD Jane Blazeby, MBChB, MD Angus G.K. McNair, PhD, FRCS Charlotte Chamberlain, PhD, MRCP |
| author_facet | Samuel Lawday, BMBS, MByRes Benjamin E. Zucker, MA, MBBS, MRCS Shona Gardner, MBChB, MRCS James Robb, MBChB, MA Lorna Leandro, MA, BM, BCh William Hollingworth, PhD Jane Blazeby, MBChB, MD Angus G.K. McNair, PhD, FRCS Charlotte Chamberlain, PhD, MRCP |
| author_sort | Samuel Lawday, BMBS, MByRes |
| collection | DOAJ |
| description | Objective:. To synthesize evidence of surgical treatment intensity, defined as a measure of the quantity of invasive procedures, received by patients in patients with cancer within a defined time period around the ‘end of life’ (EoL).
Background:. Concern regarding overly ‘aggressive’ care or high health care utilization at the EoL, particularly in cancer, is growing. The contribution surgery makes to the quality and cost of EoL care in cancer has not yet been quantified.
Methods:. This PROSPERO registered systematic review used PRIMSA guidelines to search electronic databases for observational studies detailing surgical intensity at the EoL in adult cancer patients. Intensity was compared by disease, individual characteristics, geographical region, and palliative care involvement. A risk of bias tool assessed quality and a narrative synthesis of findings was completed.
Results:. In total, 39 papers were identified in this search. Up to 79% of patients underwent invasive procedures in the last month of life. Heterogeneity in patient groups, inclusion criteria, and EoL time periods lead to huge variation in results, with treatment intention often not identified. Patient, geographical, and pathological factors, alongside involvement of palliative/hospice care, were all identified as contributors to treatment intensity variation.
Conclusions:. A significant proportion of patients with cancer undergo invasive and costly invasive procedures at the EoL. There is significant reporting heterogeneity, with variation in patient inclusion criteria and EoL timeframes, demonstrating uncertainty within the literature. Identification of the context where surgical treatment intensity at the EoL is potentially inappropriate is not currently possible. |
| format | Article |
| id | doaj-art-2566de8cc6a04cf69bfa7b9960b4203c |
| institution | Kabale University |
| issn | 2691-3593 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Wolters Kluwer Health |
| record_format | Article |
| series | Annals of Surgery Open |
| spelling | doaj-art-2566de8cc6a04cf69bfa7b9960b4203c2025-01-24T09:18:58ZengWolters Kluwer HealthAnnals of Surgery Open2691-35932024-12-0154e51410.1097/AS9.0000000000000514202412000-00019Surgical Treatment Intensity at the End of Life in Patients With Cancer: A Systematic ReviewSamuel Lawday, BMBS, MByRes0Benjamin E. Zucker, MA, MBBS, MRCS1Shona Gardner, MBChB, MRCS2James Robb, MBChB, MA3Lorna Leandro, MA, BM, BCh4William Hollingworth, PhD5Jane Blazeby, MBChB, MD6Angus G.K. McNair, PhD, FRCS7Charlotte Chamberlain, PhD, MRCP8From the * NIHR Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and University of Bristol, Bristol, UKFrom the * NIHR Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and University of Bristol, Bristol, UK† Department of General Surgery, North Bristol NHS Trust, Bristol, UK‡ Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, Bristol, UKFrom the * NIHR Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and University of Bristol, Bristol, UK‡ Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, Bristol, UKFrom the * NIHR Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and University of Bristol, Bristol, UKFrom the * NIHR Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and University of Bristol, Bristol, UK‡ Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, Bristol, UKObjective:. To synthesize evidence of surgical treatment intensity, defined as a measure of the quantity of invasive procedures, received by patients in patients with cancer within a defined time period around the ‘end of life’ (EoL). Background:. Concern regarding overly ‘aggressive’ care or high health care utilization at the EoL, particularly in cancer, is growing. The contribution surgery makes to the quality and cost of EoL care in cancer has not yet been quantified. Methods:. This PROSPERO registered systematic review used PRIMSA guidelines to search electronic databases for observational studies detailing surgical intensity at the EoL in adult cancer patients. Intensity was compared by disease, individual characteristics, geographical region, and palliative care involvement. A risk of bias tool assessed quality and a narrative synthesis of findings was completed. Results:. In total, 39 papers were identified in this search. Up to 79% of patients underwent invasive procedures in the last month of life. Heterogeneity in patient groups, inclusion criteria, and EoL time periods lead to huge variation in results, with treatment intention often not identified. Patient, geographical, and pathological factors, alongside involvement of palliative/hospice care, were all identified as contributors to treatment intensity variation. Conclusions:. A significant proportion of patients with cancer undergo invasive and costly invasive procedures at the EoL. There is significant reporting heterogeneity, with variation in patient inclusion criteria and EoL timeframes, demonstrating uncertainty within the literature. Identification of the context where surgical treatment intensity at the EoL is potentially inappropriate is not currently possible.http://journals.lww.com/10.1097/AS9.0000000000000514 |
| spellingShingle | Samuel Lawday, BMBS, MByRes Benjamin E. Zucker, MA, MBBS, MRCS Shona Gardner, MBChB, MRCS James Robb, MBChB, MA Lorna Leandro, MA, BM, BCh William Hollingworth, PhD Jane Blazeby, MBChB, MD Angus G.K. McNair, PhD, FRCS Charlotte Chamberlain, PhD, MRCP Surgical Treatment Intensity at the End of Life in Patients With Cancer: A Systematic Review Annals of Surgery Open |
| title | Surgical Treatment Intensity at the End of Life in Patients With Cancer: A Systematic Review |
| title_full | Surgical Treatment Intensity at the End of Life in Patients With Cancer: A Systematic Review |
| title_fullStr | Surgical Treatment Intensity at the End of Life in Patients With Cancer: A Systematic Review |
| title_full_unstemmed | Surgical Treatment Intensity at the End of Life in Patients With Cancer: A Systematic Review |
| title_short | Surgical Treatment Intensity at the End of Life in Patients With Cancer: A Systematic Review |
| title_sort | surgical treatment intensity at the end of life in patients with cancer a systematic review |
| url | http://journals.lww.com/10.1097/AS9.0000000000000514 |
| work_keys_str_mv | AT samuellawdaybmbsmbyres surgicaltreatmentintensityattheendoflifeinpatientswithcancerasystematicreview AT benjaminezuckermambbsmrcs surgicaltreatmentintensityattheendoflifeinpatientswithcancerasystematicreview AT shonagardnermbchbmrcs surgicaltreatmentintensityattheendoflifeinpatientswithcancerasystematicreview AT jamesrobbmbchbma surgicaltreatmentintensityattheendoflifeinpatientswithcancerasystematicreview AT lornaleandromabmbch surgicaltreatmentintensityattheendoflifeinpatientswithcancerasystematicreview AT williamhollingworthphd surgicaltreatmentintensityattheendoflifeinpatientswithcancerasystematicreview AT janeblazebymbchbmd surgicaltreatmentintensityattheendoflifeinpatientswithcancerasystematicreview AT angusgkmcnairphdfrcs surgicaltreatmentintensityattheendoflifeinpatientswithcancerasystematicreview AT charlottechamberlainphdmrcp surgicaltreatmentintensityattheendoflifeinpatientswithcancerasystematicreview |